ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM (TESSTAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00490789
Recruitment Status : Unknown
Verified April 2008 by Cardiff University.
Recruitment status was:  Active, not recruiting
First Posted : June 25, 2007
Last Update Posted : April 30, 2008
Sponsor:
Collaborators:
University of Nottingham
St Georges Hospital Medical School
Royal Sussex County Hospital
The Tuberous Sclerosis Association
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Cardiff University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2009
  Estimated Study Completion Date : September 2009

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 May 18, 2012 June 19, 2012
2 January 30, 2017 March 22, 2017